We are live on ! Find out more
BC

BIT Capital Portfolio holdings

AUM $2.07B
1-Year Est. Return 157.17%
This Fund
S&P 500
This Quarter Est. Return
+51.32%
1 Year Est. Return
+157.17%
3 Year Est. Return
+781.63%
5 Year Est. Return
+899.06%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$162M
Cap. Flow
-$113M
Cap. Flow %
-11.1%
Top 10 Hldgs %
57.87%
Holding
149
New
27
Increased
34
Reduced
25
Closed
54

Top Buys

Rank Stock Value
1
GRND icon
Grindr
GRND
+$38.4M
2
OPEN icon
Opendoor
OPEN
+$22.7M
3
SE icon
Sea Limited
SE
+$20.2M
4
COIN icon
Coinbase
COIN
+$19.1M
5
KEEL
Keel Infrastructure Corp
KEEL
+$15.5M

Top Sells

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$39.8M
2
HIMS icon
Hims & Hers Health
HIMS
+$23.1M
3
NVDA icon
NVIDIA
NVDA
+$22.1M
4
UBER icon
Uber
UBER
+$19.8M
5
TSLA icon
Tesla
TSLA
+$18.8M

Sector Composition

Rank Sector Weight
1 Financials 37.19%
2 Technology 28.32%
3 Consumer Discretionary 8.83%
4 Healthcare 8.07%
5 Real Estate 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLDX icon
76
Celldex Therapeutics
CLDX
$2.77B
$171K 0.02%
+4,313
New +$127K
INZY
77
DELISTED
Inozyme Pharma
INZY
$161K 0.02%
37,837
+8,708
+30% +$30.9K
MGNX icon
78
MacroGenics
MGNX
$285M
$153K 0.02%
+15,902
New +$110K
IDYA icon
79
IDEAYA Biosciences
IDYA
$3.47B
$151K 0.01%
+4,237
New +$126K
ATAI icon
80
AtaiBeckley Inc
ATAI
$2.66B
$146K 0.01%
103,232
– –
VRDN icon
81
Viridian Therapeutics
VRDN
$1.99B
$144K 0.01%
+6,593
New +$104K
RCUS icon
82
Arcus Biosciences
RCUS
$3.44B
$134K 0.01%
+7,000
New +$112K
ETNB
83
DELISTED
89bio
ETNB
$124K 0.01%
11,127
+5,415
+95% +$49.8K
XNCR icon
84
Xencor
XNCR
$1.3B
$115K 0.01%
5,418
– –
RYTM icon
85
Rhythm Pharmaceuticals
RYTM
$7.31B
$114K 0.01%
+2,489
New +$78.5K
INCY icon
86
Incyte
INCY
$23.4B
$113K 0.01%
+1,800
New +$102K
DCPH
87
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$110K 0.01%
+6,822
New +$87K
DAWN
88
DELISTED
Day One Biopharmaceuticals
DAWN
$108K 0.01%
+7,430
New +$90.1K
STTK icon
89
Shattuck Labs
STTK
$719M
$101K 0.01%
+14,152
New +$38.6K
ATNM icon
90
Actinium Pharmaceuticals
ATNM
$28.9M
$100K 0.01%
+19,776
New +$102K
IMTX icon
91
Immatics
IMTX
$1.31B
$100K 0.01%
9,524
+4,381
+85% +$40.3K
KYMR icon
92
Kymera Therapeutics
KYMR
$9.52B
$99.5K 0.01%
+3,910
New +$69.9K
HARP
93
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$84.2K 0.01%
+7,407
New +$58.2K
RARE icon
94
Ultragenyx Pharmaceutical
RARE
$2.88B
$74.4K 0.01%
+1,555
New +$60.3K
MIST icon
95
Milestone Pharmaceuticals
MIST
$148M
$33.4K ﹤0.01%
20,000
-187,276
-90% -$508K
AEHR icon
96
Aehr Test Systems
AEHR
$2.63B
– –
-10,468
Closed -$478K
AKRO
97
DELISTED
Akero Therapeutics
AKRO
– –
-4,276
Closed -$216K
AMD icon
98
Advanced Micro Devices
AMD
$808B
– –
-23,163
Closed -$2.38M
APLD icon
99
CALL
Applied Digital
APLD
$7.37B
– –
-132,000
Closed -$824K
APTV icon
100
Aptiv
APTV
$12.2B
– –
-1,287
Closed -$127K
2 3
4
5 6

Similar funds

HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.07B AUM 19% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.07B AUM 4.33% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
3AM
3EDGE Asset Management Naples, Florida $2.07B AUM 16.66% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

BIT Capital's Q4 2023 Portfolio in Review

As of Q4 2023, BIT Capital held 149 positions worth $1.02B, up 19% from $855M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

BIT Capital withdrew a net $113M in Q4 2023, closing 54 positions and reducing 25 holdings. Its most notable exit was Criteo, an estimated $18.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, BIT Capital opened a new position in Axon Enterprise worth $9.22M.

  • BIT Capital's largest Q4 2023 buy was Axon Enterprise: 35,686 shares worth $9.22M.
  • BIT Capital added most to Grindr in Q4 2023, an estimated $38.4M increase.
  • BIT Capital's biggest Q4 2023 reduction was Affirm, cutting an estimated $39.8M.
  • BIT Capital fully exited Criteo in Q4 2023, selling an estimated $18.5M.
  • BIT Capital's ten largest holdings make up 58% of its $1.02B portfolio in Q4 2023.
  • BIT Capital opened 27 new positions and closed 54 in Q4 2023.
  • BIT Capital's portfolio value rose 19% quarter-over-quarter to $1.02B.

Based on BIT Capital's 13F filing for Q4 2023, filed 12 Feb 2025.